Nuclear morphometry and chromatin texture changes in hepatocellular carcinoma samples may predict outcomes of liver transplanted patients.

Jordan Boeira Dos Santos, Rodrigo Tzovenos Starosta, Emily Ferreira Salles Pilar, Jefferson Daniel Kunz, Joelson Tomedi, Carlos Thadeu Schmidt Cerski, Rúbia Denise Ruppenthal
Author Information
  1. Jordan Boeira Dos Santos: Graduate Program in Science in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. jordansantos@hcpa.edu.br. ORCID
  2. Rodrigo Tzovenos Starosta: Department of Pediatrics, Saint Louis Children's Hospital, Washington University, Saint Louis, MO, USA. ORCID
  3. Emily Ferreira Salles Pilar: Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. ORCID
  4. Jefferson Daniel Kunz: Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. ORCID
  5. Joelson Tomedi: Department of Surgical Pathology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
  6. Carlos Thadeu Schmidt Cerski: Graduate Program in Science in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. ORCID
  7. Rúbia Denise Ruppenthal: Graduate Program in Science in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. ORCID

Abstract

BACKGROUND: Nuclear changes are typical in the carcinogenesis of hepatocellular carcinoma (HCC). Morphometry and chromatin texture analysis are quantitative methods for their quantification. In this study, we analyzed nuclear morphometry and chromatin texture parameters in samples of hepatocellular carcinoma from liver transplant patients and their associations with clinicopathologic variables.
METHODS: Samples of HCC and adjacent tissue from 34 individuals were collected in tissue microarray blocks. Stained slides were microphotographed using an optical microscope and nuclear parameters analyzed in ImageJ (FracLac plug-in). ROC curve analysis was used to find accurate cut-offs for differentiation of neoplastic and non-neoplastic cells. The inter-rater agreement was also evaluated.
RESULTS: Nuclear morphometric and textural differences were observed between the samples of HCC and adjacent tissue of liver transplant patients. Lower mean gray value (p = 0.034) and Feret diameter (p = 0.024) were associated with higher Model for End-Stage Liver Disease (MELD) scores. Nuclei with larger area (p = 0.014) and larger Feret diameter (p = 0.035) were associated with lower survival. Lower aspect ratio was associated with HCC recurrence after the transplant (p = 0.048). The cut-off of 1.13 μm (p =  < 0.001) for aspect ratio and cut-off of 21.15 μm (p = 0.038) for perimeter were established for the differentiation of neoplastic and non-neoplastic cells. The morphometric analysis was reproducible to area, circularity, Feret diameter, mean gray value and aspect ratio between observers (p =  < 0.001).
CONCLUSIONS: Nuclear morphometric differences between the HCC and the adjacent tissue samples were associated with prognostic variables (MELD scores, recurrence and survival) and may predict liver transplant patients' outcomes.

Keywords

References

  1. Pathologica. 1995 Jun;87(3):286-99 [PMID: 8570289]
  2. Oncol Rep. 2019 Jan;41(1):133-142 [PMID: 30542735]
  3. Nat Rev Cancer. 2004 Sep;4(9):677-87 [PMID: 15343274]
  4. J BUON. 2013 Apr-Jun;18(2):471-6 [PMID: 23818364]
  5. Ultrastruct Pathol. 2018 Mar-Apr;42(2):97-107 [PMID: 29424576]
  6. Life Sci Alliance. 2019 Oct 15;2(5): [PMID: 31615920]
  7. Asian Pac J Cancer Prev. 2014;15(16):6919-22 [PMID: 25169546]
  8. Melanoma Res. 2019 Oct;29(5):474-482 [PMID: 30839356]
  9. Gastroenterology Res. 2019 Dec;12(6):288-298 [PMID: 31803308]
  10. An Bras Dermatol. 2015 Nov-Dec;90(6):874-8 [PMID: 26734870]
  11. J Clin Transl Hepatol. 2014 Sep;2(3):176-81 [PMID: 26357625]
  12. World J Gastrointest Oncol. 2019 Apr 15;11(4):322-334 [PMID: 31040897]
  13. Cancer Lett. 2014 Jan 28;342(2):223-30 [PMID: 22306342]
  14. Nat Med. 1998 Jul;4(7):844-7 [PMID: 9662379]
  15. Liver Int. 2017 May;37(5):717-726 [PMID: 28199760]
  16. Biomed Res Int. 2014;2014:239706 [PMID: 25025042]
  17. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  18. Cancer Res. 1984 Oct;44(10):4217-23 [PMID: 6467183]
  19. Autops Case Rep. 2021 Aug 20;11:e2021306 [PMID: 34458174]
  20. J Clin Exp Hepatol. 2013 Mar;3(1):50-60 [PMID: 25755471]
  21. Ann Thorac Cardiovasc Surg. 2018 Dec 20;24(6):303-307 [PMID: 30089760]
  22. Gland Surg. 2020 Apr;9(2):238-244 [PMID: 32420247]
  23. Nat Methods. 2012 Jul;9(7):671-5 [PMID: 22930834]
  24. Rom J Morphol Embryol. 2011;52(3):845-54 [PMID: 21892528]

MeSH Term

Carcinoma, Hepatocellular
Chromatin
End Stage Liver Disease
Humans
Liver Neoplasms
Retrospective Studies
Severity of Illness Index

Chemicals

Chromatin

Word Cloud

Created with Highcharts 10.0.0p = 0HCCtransplantNuclearcarcinomatexturesamplestissueassociatedhepatocellularchromatinanalysisliverpatientsadjacentmorphometricFeretdiameteraspectratiochangesMorphometryanalyzednuclearmorphometryparametersvariablesdifferentiationneoplasticnon-neoplasticcellsdifferencesLowermeangrayvalueLiverMELDscoreslargerareasurvivalrecurrencecut-offp =  < 0001maypredictoutcomesBACKGROUND:typicalcarcinogenesisquantitativemethodsquantificationstudyassociationsclinicopathologicMETHODS:Samples34individualscollectedmicroarrayblocksStainedslidesmicrophotographedusingopticalmicroscopeImageJFracLacplug-inROCcurveusedfindaccuratecut-offsinter-rateragreementalsoevaluatedRESULTS:texturalobserved034024higherModelEnd-StageDiseaseNuclei014035lower048113 μm2115 μm038perimeterestablishedreproduciblecircularityobserversCONCLUSIONS:prognosticpatients'of livertransplantedChromatinHepatocellular

Similar Articles

Cited By